Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Table 1

Demographic features and outcomes of cytoreductive surgery in ten patients undergoing adjuvant chemotherapy with intraperitoneal pemetrexed and intravenous cisplatin for diffuse malignant peritoneal mesothelioma.

	Number of patients
Total	10
Female	3
Male	7
Age
Mean	51
Range	23–69
Peritoneal cancer index (PCI)
Mean	24
Range	7–39
CC score
CC 0/1	4
CC 2	4
CC 3	2
Visceral sparing cytoreduction	8
Colon resection	2